[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Insulin Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Product Type

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Short Acting Human Insulin

4.3       Intermediate Acting Human Insulin

4.4       Long Acting Human Insulin

4.5       Fast Acting Human Insulin

4.6       Premixed Human Insulin

5        By Delivery System

5.1       Introduction 

5.1.1    Market Size & Forecast (Value)

5.2       Syringes

5.3       Pens

5.4       Pens needles

5.5       Pumps

6.         By Application  

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       Type II Diabetes,

6.3       Type I Diabetes,

6.4       Gestational Diabetes

6.5       Prediabetes

7          Regional

7.1       Introduction

7.1.1    Market Size & Forecast (Value)

7.2       America

7.2.1    North America

7.2.1.1 U.S.

7.2.1.1.1          By Product Type

7.2.1.1.2          By Delivery System

7.2.1.2 Canada

7.2.1.2.1          By Product Type

7.2.1.2.2          By Delivery System

7.2.1.3 Mexico

7.2.1.3.1          By Product Type

7.2.1.3.2          By Delivery System

7.2.2    Latin America

7.2.2.1 By Product Type

7.2.2.2 By Delivery System

7.3       Europe

7.3.1    Market Size & Forecast (Value)

7.3.2    Germany

7.3.2.1 By Product Type

7.3.2.2 By Delivery System

7.3.3    France

7.3.3.1 By Product Type

7.3.3.2 By Delivery System

7.3.4    U.K.

7.3.4.1 By Product Type

7.3.4.2 By Delivery System

7.3.5    Italy

7.3.5.1 By Product Type

7.3.5.2 By Delivery System

7.3.6    Spain

7.3.6.1 By Product Type

7.3.6.2 By Delivery System

7.3.7    Rest of Europe

7.3.7.1 By Product Type

7.3.7.2 By Delivery System

7.4       Asia Pacific

7.4.1    Market Size & Forecast (Value)

7.4.2    Japan

7.4.2.1 By Product Type

7.4.2.2 By Delivery System

7.4.3    China

7.4.3.1 By Delivery System

7.4.3.2 By Delivery System

7.4.4    Australia

7.4.4.1 By Product Type

7.4.4.2 By Delivery System

7.4.5    India

7.4.5.1 By Product Type

7.4.5.2 By Delivery System

7.4.6    South Korea

7.4.6.1 By Product Type

7.4.6.2 By Delivery System

7.4.7    Rest of Asia-Pacific

7.4.7.1 By Product Type

7.4.7.2 By Delivery System

7.5       Middle East & Africa

7.5.1    Market Size & Forecast (Value)

7.5.2    Saudi Arabia

7.5.2.1 By Product Type

7.5.2.2 By Delivery System  

7.5.3    South Africa

7.5.3.1 By Product Type

7.5.3.2 By Delivery System  

7.5.4    Kuwait

7.5.4.1 By Product Type

7.5.4.2 By Delivery System  

7.5.5    Rest of Middle East & Africa

7.5.5.1 By Product Type

7.5.5.2 By Delivery System  

8.         Company Profile

8.1       Life scan Inc.

8.1.1    Company Overview

8.1.2    Financial Performance

8.1.3    Recent Developments

8.1.4    Product Portfolio

8.2       Becton, Dickinson and Co.

8.2.1    Company Overview

8.2.2    Financial Performance

8.2.3    Recent Developments

8.2.4    Product Portfolio

8.3       Terumo Corporation

8.3.1    Company Overview

8.3.2    Financial Performance

8.3.3    Recent Developments

8.3.4    Product Portfolio

8.4       Acon Laboratories Inc.

8.4.1    Company Overview

8.4.2    Financial Performance

8.4.3    Recent Developments

8.4.4    Product Portfolio

8.5       Roche Diagnostics Ltd.

8.5.1    Company Overview

8.5.2    Financial Performance

8.5.3    Recent Developments

8.5.4    Product Portfolio

8.6       Johnson & Johnson

8.6.1    Company Overview

8.6.2    Financial Performance

8.6.3    Recent Developments

8.6.4    Product Portfolio

8.7       ARKRAY Inc.

8.7.1    Company Overview

8.7.2    Financial Performance

8.7.3    Recent Developments

8.7.4    Product Portfolio

8.8       Novo Nordisk A/S

8.8.1    Company Overview

8.8.2    Financial Performance

8.8.3    Recent Developments

8.8.4    Product Portfolio

8.9       Medtronic

8.9.1    Company Overview

8.9.2    Financial Performance

8.9.3    Recent Developments

8.9.4    Product Portfolio

8.10     Abbott Laboratories

8.10.1  Company Overview

8.10.2  Financial Performance

8.10.3  Recent Developments

8.10.4  Product Portfolio

8.11     Bayer AG

8.11.1  Company Overview

8.11.2  Financial Performance

8.11.3  Recent Developments

8.11.4  Product Portfolio

8.12     Ypsomed AG

8.12.1  Company Overview

8.12.2  Financial Performance

8.12.3  Recent Developments

8.12.4  Product Portfolio

8.13     Sanofi

8.13.1  Company Overview

8.13.2  Financial Performance

8.13.3  Recent Developments

8.13.4  Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports